Prospective study for the accuracy of imaging in the diagnosis of mesangial lymph node staging in rectal cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100052441

Enrollment

Unknown

Registered

2021-10-26

Start date

2021-11-01

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

Gold Standard:Pathological examination results of rectal cancer and mesangial lymph nodes

Index test:Pathological&#32

examination&#32

results

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with rectal cancer by endoscopic biopsy and planned to undergo radical surgery within 2 weeks after imaging examination; 2. Magnetic resonance/enhanced CT imaging without contraindications; 3. Patients with >=1 lymph node on MRI/enhanced CT; 4. Agree to participate in this research activity and sign the informed consent.

Exclusion criteria

Exclusion criteria: The image of the imaging examination is not clear.

Design outcomes

Primary

Measure	Time frame
Diagnostic sensitivity;Diagnostic specificity;	—

Countries

China

Contacts

Public ContactWang Ziqiang

West China Hospital, Sichuan University

wangziqiang@scu.edu.cn+86 18980602028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026